Featured Research

from universities, journals, and other organizations

Germany: Measles not being reported, as required by German law

Date:
April 11, 2011
Source:
Deutsches Aerzteblatt International
Summary:
Measles are not always being reported in Germany as required by law, particularly when cases are sporadic.

Measles is not always being reported in Germany as required by law, particularly when cases are sporadic. In this edition of Deutsches Δrzteblatt International (Dtsch Arztebl Int 2011; 108[12]: 191-6), Annedore Mette's working group presents its conclusions.

The WHO aims to eliminate measles in Europe by 2015. The criteria for this are for there to be no measles cases among the country's inhabitants, and for any measles arriving from abroad not to spread any further within the country, as a result of the high vaccination rate and compulsory reporting.

In their study, Annedore Mette and her coauthors analyzed and evaluated data on measles diagnoses among individuals covered by statutory health insurance. Their goal was to determine the ratio between billed measles diagnoses and data gathered according to Germany's Law on Protection Against Infectious Diseases in North Rhine-Westphalia.

The results confirmed that measles was being under-reported. Possible reasons cited by physicians when asked why measles cases were not being reported as required by law included forgetting, lack of habit, uncertainty about the duty to report, lack of time, and complexity.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mette A, Reuss AM, Feig M, Kappelmayer L, Siedler A, Eckmanns T, Poggensee G. Poggensee G: Under-reporting of measles--an evaluation based on data from North Rhine-Westphalia. Dtsch Arztebl Int, 2011; 108(12): 191%u20136

Cite This Page:

Deutsches Aerzteblatt International. "Germany: Measles not being reported, as required by German law." ScienceDaily. ScienceDaily, 11 April 2011. <www.sciencedaily.com/releases/2011/04/110411083832.htm>.
Deutsches Aerzteblatt International. (2011, April 11). Germany: Measles not being reported, as required by German law. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/04/110411083832.htm
Deutsches Aerzteblatt International. "Germany: Measles not being reported, as required by German law." ScienceDaily. www.sciencedaily.com/releases/2011/04/110411083832.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins